Autopsy report · NCT06169826

Histidine Oral Supplementation as a Therapeutic Modality for Alzheimer's Disease

“withdrawn by the PI”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 4

Sponsor

Wake Forest University Health Sciences

Sponsor type

University, hospital or other

Conditions

Alzheimer Disease

Interventions

l-Histidine; Control

Participants

0

Sites

1

Countries

United States

Trials that died the same way

• Probiotics in Girls With Spina Bifida
  “Withdrawn by PI” (98% match in meaning)
• Effectiveness of Alzheimer's Universe (Www.AlzU.Org) on Knowledge and Behavior
  “PI withdrawn” (95% match in meaning)
• Conventionally vs. Digitally Fabricated Complete Dentures: Clinical Treatment Outcome Differences
  “The PI is deceased, decision was made to withdraw.” (76% match in meaning)
• EXCOR® Pediatric VAD Anticoagulation IDE
  “PI withdrew protocol” (74% match in meaning)
• Mechanical Ventilation in Severe Brain Injury: The Effect of Positive End Expiratory Pressure on Intracranial Pressure
  “Departure of PI” (71% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.